Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-28-5p AAAS -0.14 0.04976 0.33 0 miRNAWalker2 validate -0.19 0 NA
2 hsa-miR-28-5p AAGAB -0.14 0.04976 0.81 0 miRanda -0.26 0 NA
3 hsa-miR-28-5p AATK -0.14 0.04976 0.45 0.00408 miRanda -0.27 0.00027 NA
4 hsa-miR-200a-3p ABCA1 2.55 0 -1.41 0 mirMAP -0.25 0 NA
5 hsa-miR-200b-3p ABCA1 2.12 0 -1.41 0 TargetScan -0.28 0 NA
6 hsa-miR-200b-3p ABCA10 2.12 0 -4.63 0 mirMAP -0.54 0 NA
7 hsa-miR-28-5p ABCB9 -0.14 0.04976 0.95 0 miRanda -0.26 0 NA
8 hsa-miR-132-3p ABCC5 -0.04 0.6686 0.8 0 mirMAP -0.16 0.00099 NA
9 hsa-miR-28-5p ABCC5 -0.14 0.04976 0.8 0 miRanda; mirMAP -0.16 0.00553 NA
10 hsa-miR-132-3p ABCG1 -0.04 0.6686 0.66 0 MirTarget -0.24 0 NA
11 hsa-miR-28-5p ABHD1 -0.14 0.04976 -0.98 0 miRanda -0.3 7.0E-5 NA
12 hsa-miR-28-5p ABHD2 -0.14 0.04976 0.45 0.00053 mirMAP -0.25 5.0E-5 NA
13 hsa-miR-28-5p ABLIM3 -0.14 0.04976 -1.88 0 miRanda -0.64 0 NA
14 hsa-miR-28-5p ACACA -0.14 0.04976 -0.22 0.02162 miRanda -0.16 0.00043 NA
15 hsa-miR-28-5p ACAD8 -0.14 0.04976 -0.36 0 miRanda -0.12 0.00017 NA
16 hsa-miR-28-5p ACAT1 -0.14 0.04976 -0.75 0 miRanda -0.16 0.00027 NA
17 hsa-miR-28-5p ACE -0.14 0.04976 -0.33 0.00163 mirMAP -0.12 0.02054 NA
18 hsa-miR-200b-3p ACE2 2.12 0 -2.45 0 TargetScan -0.31 1.0E-5 NA
19 hsa-miR-200c-3p ACE2 2.07 0 -2.45 0 miRNATAP -0.32 2.0E-5 NA
20 hsa-miR-141-3p ACO1 3 0 -1.63 0 MirTarget; TargetScan -0.32 0 NA
21 hsa-miR-200a-3p ACO1 2.55 0 -1.63 0 MirTarget -0.26 0 NA
22 hsa-miR-28-5p ACOX3 -0.14 0.04976 0.2 0.02327 miRanda -0.18 1.0E-5 NA
23 hsa-miR-28-5p ACSF2 -0.14 0.04976 -0.26 0.05489 miRanda -0.31 0 NA
24 hsa-miR-200b-3p ACTC1 2.12 0 -1.25 0 MirTarget -0.36 0 NA
25 hsa-miR-200c-3p ACTC1 2.07 0 -1.25 0 MirTarget -0.45 0 NA
26 hsa-miR-145-5p ACTG1 -2.63 0 0.71 0 MirTarget; miRNATAP -0.12 0 NA
27 hsa-let-7e-5p ACVR1C 0.26 0.00191 -5.2 0 MirTarget; miRNATAP -0.39 0.00048 NA
28 hsa-miR-200b-3p ACVR1C 2.12 0 -5.2 0 TargetScan -0.69 0 NA
29 hsa-let-7e-5p ACVR2A 0.26 0.00191 -0.96 0 miRNATAP -0.11 0.00057 NA
30 hsa-miR-141-3p ACVR2A 3 0 -0.96 0 TargetScan; miRNATAP -0.16 0 NA
31 hsa-miR-200a-3p ACVR2A 2.55 0 -0.96 0 miRNATAP -0.14 0 NA
32 hsa-miR-200b-3p ACVR2A 2.12 0 -0.96 0 TargetScan -0.14 0 NA
33 hsa-miR-200c-3p ACVR2A 2.07 0 -0.96 0 miRNATAP -0.16 0 NA
34 hsa-miR-145-5p ADAM19 -2.63 0 1.6 0 MirTarget; miRNATAP -0.15 0 26823772 MiR 145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19; ADAM19 was identified as a direct target of miR-145; In addition a reverse correlation between miR-145 and ADAM19 expression was noted in RB tissues
35 hsa-miR-141-3p ADAM22 3 0 -1.22 0 MirTarget -0.33 0 NA
36 hsa-miR-200a-3p ADAM22 2.55 0 -1.22 0 MirTarget -0.32 0 NA
37 hsa-miR-200b-3p ADAMTS12 2.12 0 0.1 0.62063 mirMAP -0.26 0 NA
38 hsa-miR-28-5p ADAMTS13 -0.14 0.04976 0.49 0.00058 miRanda -0.25 0.0002 NA
39 hsa-miR-28-5p ADAMTS15 -0.14 0.04976 -0.94 0.00099 mirMAP -1.13 0 NA
40 hsa-miR-200b-3p ADAMTS3 2.12 0 -1.85 0 TargetScan -0.36 0 NA
41 hsa-miR-200c-3p ADAMTS3 2.07 0 -1.85 0 miRNATAP -0.38 0 NA
42 hsa-let-7e-5p ADAMTS5 0.26 0.00191 -3.55 0 miRNATAP -0.27 0.00046 NA
43 hsa-miR-200b-3p ADAMTS5 2.12 0 -3.55 0 mirMAP -0.54 0 NA
44 hsa-miR-132-3p ADAMTS6 -0.04 0.6686 1.1 0 miRNATAP -0.17 0.00258 NA
45 hsa-let-7e-5p ADAMTS8 0.26 0.00191 -1.48 0 MirTarget; miRNATAP -0.3 0.00174 NA
46 hsa-miR-141-3p ADARB1 3 0 -0.6 0 MirTarget -0.13 0 NA
47 hsa-miR-200a-3p ADARB1 2.55 0 -0.6 0 MirTarget -0.11 0 NA
48 hsa-miR-28-5p ADCK1 -0.14 0.04976 0.19 0.00451 miRanda -0.12 0.00012 NA
49 hsa-miR-28-5p ADCY1 -0.14 0.04976 -0.05 0.84149 miRanda -0.59 0 NA
50 hsa-miR-200b-3p ADCY2 2.12 0 -0.73 0.00385 MirTarget; TargetScan -0.16 0.00322 NA
51 hsa-miR-200c-3p ADCY2 2.07 0 -0.73 0.00385 MirTarget; miRNATAP -0.24 3.0E-5 NA
52 hsa-miR-28-5p ADCY6 -0.14 0.04976 -0.63 0 miRanda -0.32 0 NA
53 hsa-miR-28-5p ADCY9 -0.14 0.04976 0.12 0.23839 mirMAP -0.4 0 NA
54 hsa-miR-141-3p ADD3 3 0 -1.66 0 TargetScan -0.26 0 NA
55 hsa-miR-200b-3p ADD3 2.12 0 -1.66 0 MirTarget; TargetScan -0.27 0 NA
56 hsa-miR-200c-3p ADD3 2.07 0 -1.66 0 MirTarget -0.26 0 NA
57 hsa-miR-145-5p ADM2 -2.63 0 2.41 0 mirMAP -0.43 0 NA
58 hsa-miR-141-3p ADRB1 3 0 -2.83 0 TargetScan -0.47 0 NA
59 hsa-let-7e-5p ADRB2 0.26 0.00191 -3.09 0 MirTarget -0.36 0 NA
60 hsa-miR-132-3p AFF1 -0.04 0.6686 -0.82 0 mirMAP -0.14 9.0E-5 NA
61 hsa-miR-141-3p AFF1 3 0 -0.82 0 TargetScan -0.17 0 NA
62 hsa-miR-200b-3p AFF1 2.12 0 -0.82 0 TargetScan -0.15 0 NA
63 hsa-miR-28-5p AFF1 -0.14 0.04976 -0.82 0 miRanda -0.18 2.0E-5 NA
64 hsa-miR-28-5p AFF4 -0.14 0.04976 -0.28 0.00153 MirTarget; miRanda -0.2 0 NA
65 hsa-miR-28-5p AFTPH -0.14 0.04976 0.31 0 miRanda -0.1 0.00074 NA
66 hsa-miR-28-5p AGAP11 -0.14 0.04976 -2.72 0 miRanda -0.31 0.00022 NA
67 hsa-miR-28-5p AGBL4 -0.14 0.04976 -0.14 0.45129 miRanda -0.24 0.00912 NA
68 hsa-let-7e-5p AGMAT 0.26 0.00191 1.49 0 miRNAWalker2 validate -0.11 0.04492 NA
69 hsa-miR-200a-3p AGPAT4 2.55 0 -0.74 0 mirMAP -0.18 0 NA
70 hsa-miR-200b-3p AHNAK 2.12 0 -1.77 0 TargetScan -0.26 0 NA
71 hsa-miR-28-5p AHNAK -0.14 0.04976 -1.77 0 PITA; miRanda; miRNATAP -0.27 0 NA
72 hsa-miR-141-3p AHR 3 0 -0.98 0 MirTarget -0.16 0 NA
73 hsa-miR-200a-3p AHR 2.55 0 -0.98 0 MirTarget -0.12 0 NA
74 hsa-miR-145-5p AIFM1 -2.63 0 0.67 0 miRNATAP -0.13 0 20332243 Artificial overexpression of miR145 by using adenoviral vectors in prostate cancer PC-3 and DU145 cells significantly downregulated BNIP3 together with the upregulation of AIF reduced cell growth and increased cell death
75 hsa-miR-141-3p AKAP11 3 0 -0.85 0 MirTarget; TargetScan -0.14 0 NA
76 hsa-miR-200a-3p AKAP11 2.55 0 -0.85 0 MirTarget -0.13 0 NA
77 hsa-miR-200b-3p AKAP13 2.12 0 -0.61 0 mirMAP -0.12 0 NA
78 hsa-miR-141-3p AKAP2 3 0 -2.14 0 TargetScan -0.43 0 NA
79 hsa-miR-200b-3p AKAP2 2.12 0 -2.14 0 TargetScan -0.41 0 NA
80 hsa-let-7e-5p AKAP6 0.26 0.00191 -2.28 0 MirTarget -0.14 0.02017 NA
81 hsa-miR-200c-3p AKAP7 2.07 0 -1.02 0 miRNATAP -0.19 0 NA
82 hsa-miR-28-5p AKR7A2 -0.14 0.04976 0.34 1.0E-5 miRanda -0.24 0 NA
83 hsa-miR-143-3p AKT1 -1.23 0 0.68 0 miRNAWalker2 validate -0.11 0 NA
84 hsa-miR-28-5p ALDH3A2 -0.14 0.04976 -0.86 0 miRanda -0.29 0 NA
85 hsa-miR-28-5p AMIGO2 -0.14 0.04976 -1.58 0 miRanda -0.24 0.00784 NA
86 hsa-miR-143-3p AMMECR1 -1.23 0 0.82 0 miRNATAP -0.11 0.00012 NA
87 hsa-let-7e-5p AMOT 0.26 0.00191 -0.91 0 MirTarget -0.16 0.00199 NA
88 hsa-miR-141-3p AMOTL1 3 0 -1.81 0 TargetScan -0.36 0 NA
89 hsa-miR-200b-3p AMOTL2 2.12 0 -1.57 0 MirTarget; TargetScan -0.2 0 NA
90 hsa-miR-200c-3p AMOTL2 2.07 0 -1.57 0 MirTarget; miRNATAP -0.29 0 NA
91 hsa-miR-28-5p AMPH -0.14 0.04976 -0.23 0.25767 MirTarget; PITA; miRanda -0.38 8.0E-5 NA
92 hsa-let-7e-5p AMT 0.26 0.00191 -1.27 0 MirTarget -0.12 0.04175 NA
93 hsa-miR-28-5p AMZ1 -0.14 0.04976 2.49 0 miRanda -0.45 0.00014 NA
94 hsa-miR-28-5p ANGEL1 -0.14 0.04976 -0.24 5.0E-5 miRanda -0.14 0 NA
95 hsa-miR-141-3p ANGPTL1 3 0 -3.72 0 MirTarget -0.83 0 NA
96 hsa-miR-200a-3p ANGPTL1 2.55 0 -3.72 0 MirTarget -0.66 0 NA
97 hsa-miR-141-3p ANK2 3 0 -2.51 0 TargetScan; miRNATAP -0.57 0 NA
98 hsa-miR-200a-3p ANK2 2.55 0 -2.51 0 miRNATAP -0.46 0 NA
99 hsa-miR-200b-3p ANKH 2.12 0 -0.31 0.00327 TargetScan -0.13 0 NA
100 hsa-miR-200c-3p ANKH 2.07 0 -0.31 0.00327 miRNATAP -0.16 0 NA
101 hsa-miR-141-3p ANKRD44 3 0 -0.72 0 TargetScan -0.21 0 NA
102 hsa-miR-28-5p ANKS1B -0.14 0.04976 0.2 0.2194 miRanda -0.42 0 NA
103 hsa-miR-28-5p ANKS3 -0.14 0.04976 0.72 0 miRanda -0.16 0.0011 NA
104 hsa-miR-141-3p ANO5 3 0 -1.99 0 mirMAP -0.34 0 NA
105 hsa-miR-200a-3p ANO5 2.55 0 -1.99 0 mirMAP -0.31 0 NA
106 hsa-miR-200b-3p ANO5 2.12 0 -1.99 0 TargetScan -0.37 0 NA
107 hsa-miR-141-3p ANO6 3 0 -1.5 0 MirTarget; TargetScan -0.28 0 NA
108 hsa-miR-200a-3p ANO6 2.55 0 -1.5 0 MirTarget -0.26 0 NA
109 hsa-miR-200b-3p ANO6 2.12 0 -1.5 0 TargetScan -0.28 0 NA
110 hsa-miR-28-5p ANXA9 -0.14 0.04976 1.78 0 miRanda -1.05 0 NA
111 hsa-miR-200b-3p AP1S2 2.12 0 -0.5 0 MirTarget; TargetScan -0.17 0 NA
112 hsa-miR-200c-3p AP1S2 2.07 0 -0.5 0 MirTarget; miRNATAP -0.2 0 NA
113 hsa-miR-28-5p AP2A2 -0.14 0.04976 0.03 0.55943 miRanda -0.12 0 NA
114 hsa-miR-28-5p AP2B1 -0.14 0.04976 0.26 0.00183 miRanda -0.22 0 NA
115 hsa-miR-141-3p APBB2 3 0 -0.39 0.0002 MirTarget; TargetScan -0.11 0 NA
116 hsa-miR-28-5p APC2 -0.14 0.04976 0.94 0 mirMAP -0.27 0.00015 NA
117 hsa-miR-145-5p APH1A -2.63 0 0.88 0 miRNAWalker2 validate -0.18 0 NA
118 hsa-miR-141-3p APOLD1 3 0 -1.8 0 TargetScan -0.33 0 NA
119 hsa-miR-141-3p AQP4 3 0 -2.95 0 mirMAP -0.25 0 NA
120 hsa-miR-200a-3p AQP4 2.55 0 -2.95 0 mirMAP -0.2 6.0E-5 NA
121 hsa-miR-200b-3p AQP4 2.12 0 -2.95 0 mirMAP -0.15 0.00477 NA
122 hsa-miR-200c-3p AQP4 2.07 0 -2.95 0 mirMAP -0.16 0.00987 NA
123 hsa-miR-132-3p AR -0.04 0.6686 -1 0.00094 mirMAP -0.58 0 NA
124 hsa-miR-141-3p AR 3 0 -1 0.00094 mirMAP -0.28 0 26062412; 22314666 miR 141 3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells; After prostate cancer cell line LNCaP was transfected with miR-141-3p mimics expression levels of AR mRNA and protein in the LNCaP cells were detected by reverse transcription PCR and Western blotting respectively; The 3'untranslated regions 3'UTR of AR mRNA containing the binding site of miR-141-3p was amplified by PCR and inserted into pmiR-report vector a 3'downstream luciferase reporter gene; Transfection of miR-141-3p mimics decreased both mRNA and protein expression levels of AR in LNCaP cells; AR is a direct target gene of miR-141-3p;miR 141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein; Here we investigated the correlation of Shp expression with the cellular level of miR-141 and its effects on AR transcriptional activity in non-malignant and malignant human prostate epithelial cell lines; Phenethyl isothiocyanate a natural constituent of many edible cruciferous vegetables increased Shp expression downregulated miR-141 and inhibited AR transcriptional activity in LNCaP cells; Shp is a target for miR-141 and it is downregulated in cultured human PCa cells with the involvement of upregulation of miR-141 which promotes AR transcriptional activity
125 hsa-miR-200a-3p AR 2.55 0 -1 0.00094 mirMAP -0.29 0 24391862 We identified miR-200 b as a downstream target of androgen receptor and linked its expression to decreased tumorigenicity and metastatic capacity of the prostate cancer cells
126 hsa-miR-28-5p ARAF -0.14 0.04976 0.24 1.0E-5 miRanda; miRNATAP -0.11 4.0E-5 NA
127 hsa-let-7e-5p ARHGAP20 0.26 0.00191 -3.51 0 miRNATAP -0.17 0.03118 NA
128 hsa-miR-200b-3p ARHGAP20 2.12 0 -3.51 0 MirTarget; TargetScan -0.59 0 NA
129 hsa-miR-200c-3p ARHGAP20 2.07 0 -3.51 0 MirTarget; miRNATAP -0.69 0 NA
130 hsa-miR-141-3p ARHGAP23 3 0 -0.93 0 TargetScan -0.23 0 NA
131 hsa-miR-141-3p ARHGAP24 3 0 -1.41 0 TargetScan; miRNATAP -0.33 0 NA
132 hsa-miR-200a-3p ARHGAP24 2.55 0 -1.41 0 miRNATAP -0.28 0 NA
133 hsa-let-7e-5p ARHGAP26 0.26 0.00191 -1.51 0 mirMAP -0.31 0 NA
134 hsa-miR-200b-3p ARHGAP26 2.12 0 -1.51 0 TargetScan -0.22 0 NA
135 hsa-miR-200b-3p ARHGAP28 2.12 0 -1.18 0 MirTarget -0.37 0 NA
136 hsa-miR-200c-3p ARHGAP28 2.07 0 -1.18 0 MirTarget -0.43 0 NA
137 hsa-miR-132-3p ARHGAP32 -0.04 0.6686 0.43 9.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.22 0 NA
138 hsa-miR-28-5p ARHGAP32 -0.14 0.04976 0.43 9.0E-5 miRanda -0.36 0 NA
139 hsa-miR-200b-3p ARHGAP6 2.12 0 -1.65 0 MirTarget; TargetScan -0.34 0 NA
140 hsa-miR-200c-3p ARHGAP6 2.07 0 -1.65 0 MirTarget -0.46 0 NA
141 hsa-miR-28-5p ARHGAP8 -0.14 0.04976 1.29 0 miRanda -0.12 0.04559 NA
142 hsa-let-7e-5p ARHGEF15 0.26 0.00191 -1.85 0 MirTarget; miRNATAP -0.12 0.01568 NA
143 hsa-miR-28-5p ARHGEF16 -0.14 0.04976 1.35 0 miRanda -0.31 0 NA
144 hsa-let-7e-5p ARHGEF38 0.26 0.00191 0.07 0.77513 miRNATAP -0.36 0.0002 NA
145 hsa-miR-200b-3p ARHGEF6 2.12 0 -1.7 0 mirMAP -0.28 0 NA
146 hsa-miR-132-3p ARID2 -0.04 0.6686 0.01 0.8705 MirTarget; miRNATAP -0.16 0 NA
147 hsa-miR-141-3p ARID5B 3 0 -1.75 0 TargetScan; miRNATAP -0.28 0 NA
148 hsa-miR-200a-3p ARID5B 2.55 0 -1.75 0 miRNATAP -0.24 0 NA
149 hsa-miR-200b-3p ARID5B 2.12 0 -1.75 0 TargetScan -0.25 0 NA
150 hsa-miR-141-3p ARL10 3 0 -1.27 0 mirMAP -0.26 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 CARDIOVASCULAR SYSTEM DEVELOPMENT 160 788 5.742e-28 1.336e-24
2 CIRCULATORY SYSTEM DEVELOPMENT 160 788 5.742e-28 1.336e-24
3 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 251 1672 1.33e-22 2.055e-19
4 VASCULATURE DEVELOPMENT 106 469 1.766e-22 2.055e-19
5 REGULATION OF CELL DIFFERENTIATION 230 1492 3.447e-22 3.208e-19
6 TISSUE DEVELOPMENT 227 1518 3.401e-20 2.638e-17
7 NEUROGENESIS 213 1402 9.035e-20 6.006e-17
8 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 183 1142 1.778e-19 1.034e-16
9 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 167 1021 1.045e-18 5.403e-16
10 CELL DEVELOPMENT 212 1426 1.456e-18 6.773e-16
11 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 193 1275 9.183e-18 3.884e-15
12 SKELETAL SYSTEM DEVELOPMENT 94 455 2.672e-17 1.036e-14
13 ORGAN MORPHOGENESIS 142 841 3.259e-17 1.166e-14
14 RESPONSE TO ENDOGENOUS STIMULUS 208 1450 1.775e-16 5.901e-14
15 REGULATION OF NEURON DIFFERENTIATION 105 554 2.031e-16 6.3e-14
16 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 153 957 2.723e-16 7.92e-14
17 HEART DEVELOPMENT 93 466 3.997e-16 1.051e-13
18 POSITIVE REGULATION OF CELL DIFFERENTIATION 137 823 4.065e-16 1.051e-13
19 REGULATION OF CELLULAR COMPONENT MOVEMENT 130 771 8.711e-16 2.133e-13
20 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 120 689 1.045e-15 2.432e-13
21 BLOOD VESSEL MORPHOGENESIS 78 364 1.775e-15 3.934e-13
22 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 198 1395 3.15e-15 6.663e-13
23 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 224 1656 8.071e-15 1.633e-12
24 CENTRAL NERVOUS SYSTEM DEVELOPMENT 139 872 8.943e-15 1.734e-12
25 PROTEIN PHOSPHORYLATION 147 944 1.038e-14 1.931e-12
26 POSITIVE REGULATION OF MOLECULAR FUNCTION 237 1791 1.413e-14 2.529e-12
27 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 130 801 1.764e-14 3.025e-12
28 REGULATION OF CELL DEVELOPMENT 134 836 1.82e-14 3.025e-12
29 REGULATION OF HYDROLASE ACTIVITY 188 1327 2.08e-14 3.337e-12
30 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 123 750 4.343e-14 6.519e-12
31 LOCOMOTION 164 1114 4.254e-14 6.519e-12
32 HEAD DEVELOPMENT 118 709 5.143e-14 7.478e-12
33 REGULATION OF PHOSPHORUS METABOLIC PROCESS 217 1618 5.61e-14 7.909e-12
34 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 92 498 7.658e-14 1.048e-11
35 POSITIVE REGULATION OF CATALYTIC ACTIVITY 206 1518 8.384e-14 1.115e-11
36 INTRACELLULAR SIGNAL TRANSDUCTION 211 1572 1.223e-13 1.581e-11
37 CELL MOTILITY 131 835 1.862e-13 2.236e-11
38 LOCALIZATION OF CELL 131 835 1.862e-13 2.236e-11
39 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 232 1784 1.874e-13 2.236e-11
40 UROGENITAL SYSTEM DEVELOPMENT 65 299 2.014e-13 2.343e-11
41 CELLULAR COMPONENT MORPHOGENESIS 138 900 2.416e-13 2.741e-11
42 MUSCLE STRUCTURE DEVELOPMENT 81 432 1.092e-12 1.21e-10
43 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 145 983 1.238e-12 1.34e-10
44 EMBRYO DEVELOPMENT 135 894 1.409e-12 1.49e-10
45 NEGATIVE REGULATION OF CELL DIFFERENTIATION 102 609 1.927e-12 1.993e-10
46 EPITHELIUM DEVELOPMENT 140 945 2.254e-12 2.278e-10
47 TUBE DEVELOPMENT 95 552 2.301e-12 2.278e-10
48 REGULATION OF PROTEIN MODIFICATION PROCESS 220 1710 2.599e-12 2.52e-10
49 REGULATION OF NEURON PROJECTION DEVELOPMENT 77 408 2.838e-12 2.695e-10
50 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 90 513 2.973e-12 2.712e-10
51 REGULATION OF CELL PROLIFERATION 198 1496 2.922e-12 2.712e-10
52 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 146 1004 3.112e-12 2.785e-10
53 MESENCHYME DEVELOPMENT 47 190 3.692e-12 3.241e-10
54 FOREBRAIN DEVELOPMENT 70 357 4.46e-12 3.843e-10
55 POSITIVE REGULATION OF LOCOMOTION 78 420 4.755e-12 4.023e-10
56 RESPONSE TO HORMONE 133 893 5.684e-12 4.723e-10
57 POSITIVE REGULATION OF HYDROLASE ACTIVITY 134 905 7.184e-12 5.864e-10
58 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 59 278 7.51e-12 6.025e-10
59 EMBRYONIC MORPHOGENESIS 92 539 8.29e-12 6.538e-10
60 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 145 1008 8.463e-12 6.563e-10
61 REGULATION OF CELL PROJECTION ORGANIZATION 94 558 1.047e-11 7.858e-10
62 RESPONSE TO GROWTH FACTOR 84 475 1.045e-11 7.858e-10
63 SENSORY ORGAN DEVELOPMENT 86 493 1.248e-11 9.214e-10
64 ARTERY DEVELOPMENT 27 75 1.358e-11 9.876e-10
65 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 147 1036 1.694e-11 1.176e-09
66 POSITIVE REGULATION OF GENE EXPRESSION 219 1733 1.683e-11 1.176e-09
67 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 147 1036 1.694e-11 1.176e-09
68 PHOSPHORYLATION 167 1228 2.112e-11 1.445e-09
69 REGULATION OF EPITHELIAL CELL MIGRATION 42 166 2.354e-11 1.588e-09
70 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 225 1805 3.202e-11 2.128e-09
71 REGULATION OF TRANSPORT 224 1804 5.183e-11 3.397e-09
72 REGULATION OF EPITHELIAL CELL PROLIFERATION 58 285 6.647e-11 4.296e-09
73 REGULATION OF CELL MORPHOGENESIS 91 552 7.439e-11 4.742e-09
74 AORTA DEVELOPMENT 19 41 8.348e-11 5.249e-09
75 TISSUE MORPHOGENESIS 88 533 1.421e-10 8.816e-09
76 POSITIVE REGULATION OF NEURON DIFFERENTIATION 60 306 1.512e-10 9.257e-09
77 REGULATION OF GTPASE ACTIVITY 104 673 1.57e-10 9.485e-09
78 APPENDAGE DEVELOPMENT 41 169 1.661e-10 9.783e-09
79 LIMB DEVELOPMENT 41 169 1.661e-10 9.783e-09
80 REGULATION OF CELL DEATH 188 1472 2.355e-10 1.369e-08
81 POSITIVE REGULATION OF CELL DEVELOPMENT 80 472 2.759e-10 1.585e-08
82 NEURON DIFFERENTIATION 125 874 3.699e-10 2.099e-08
83 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 30 103 4.242e-10 2.378e-08
84 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 89 554 4.711e-10 2.61e-08
85 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 154 1152 4.839e-10 2.649e-08
86 STEM CELL DIFFERENTIATION 43 190 6.341e-10 3.431e-08
87 CARDIAC CHAMBER DEVELOPMENT 36 144 8.833e-10 4.724e-08
88 NEGATIVE REGULATION OF CELL COMMUNICATION 157 1192 9.538e-10 5.043e-08
89 REGULATION OF DEVELOPMENTAL GROWTH 56 289 9.769e-10 5.107e-08
90 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 235 1977 1.058e-09 5.472e-08
91 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 62 337 1.096e-09 5.603e-08
92 ENDOTHELIAL CELL DIFFERENTIATION 24 72 1.14e-09 5.763e-08
93 EPITHELIAL CELL DIFFERENTIATION 81 495 1.195e-09 5.977e-08
94 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 187 1492 1.22e-09 6.041e-08
95 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 222 1848 1.322e-09 6.474e-08
96 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 74 437 1.35e-09 6.542e-08
97 ANGIOGENESIS 56 293 1.657e-09 7.951e-08
98 MESENCHYMAL CELL DIFFERENTIATION 34 134 1.698e-09 8.064e-08
99 EMBRYONIC ORGAN DEVELOPMENT 70 406 1.724e-09 8.102e-08
100 REGULATION OF KINASE ACTIVITY 112 776 1.875e-09 8.723e-08
101 CARDIAC SEPTUM DEVELOPMENT 26 85 1.92e-09 8.845e-08
102 EYE DEVELOPMENT 60 326 1.999e-09 9.119e-08
103 REGULATION OF CARTILAGE DEVELOPMENT 22 63 2.055e-09 9.282e-08
104 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 32 122 2.083e-09 9.32e-08
105 RESPONSE TO OXYGEN LEVELS 58 311 2.225e-09 9.861e-08
106 NEURON MIGRATION 30 110 2.417e-09 1.051e-07
107 NEGATIVE REGULATION OF CELL PROLIFERATION 97 643 2.408e-09 1.051e-07
108 REGULATION OF ACTIN FILAMENT BASED PROCESS 58 312 2.52e-09 1.086e-07
109 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 149 1135 3.317e-09 1.416e-07
110 POSITIVE REGULATION OF CELL PROLIFERATION 115 814 3.961e-09 1.675e-07
111 CONNECTIVE TISSUE DEVELOPMENT 42 194 4.13e-09 1.731e-07
112 REGULATION OF ENDOTHELIAL CELL MIGRATION 30 114 6.058e-09 2.517e-07
113 REGULATION OF CHONDROCYTE DIFFERENTIATION 18 46 7.417e-09 3.027e-07
114 ENDOTHELIUM DEVELOPMENT 26 90 7.408e-09 3.027e-07
115 REGULATION OF SYSTEM PROCESS 80 507 8.273e-09 3.347e-07
116 POSITIVE REGULATION OF KINASE ACTIVITY 77 482 9.12e-09 3.658e-07
117 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 92 616 1.033e-08 4.11e-07
118 ENDOCRINE SYSTEM DEVELOPMENT 31 123 1.043e-08 4.113e-07
119 MORPHOGENESIS OF AN EPITHELIUM 67 400 1.27e-08 4.964e-07
120 REGULATION OF TRANSFERASE ACTIVITY 127 946 1.384e-08 5.365e-07
121 CARDIAC VENTRICLE DEVELOPMENT 28 106 1.762e-08 6.776e-07
122 MORPHOGENESIS OF A BRANCHING STRUCTURE 37 167 1.785e-08 6.81e-07
123 GLIOGENESIS 38 175 2.052e-08 7.762e-07
124 REGULATION OF PHOSPHOLIPASE C ACTIVITY 16 39 2.275e-08 8.469e-07
125 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 16 39 2.275e-08 8.469e-07
126 RESPONSE TO WOUNDING 85 563 2.296e-08 8.477e-07
127 ACTIN FILAMENT BASED PROCESS 72 450 2.591e-08 9.419e-07
128 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 168 1360 2.591e-08 9.419e-07
129 RESPONSE TO OXYGEN CONTAINING COMPOUND 170 1381 2.71e-08 9.776e-07
130 REGULATION OF CELL ADHESION 92 629 2.872e-08 1.028e-06
131 NEURON PROJECTION MORPHOGENESIS 66 402 3.611e-08 1.283e-06
132 SKELETAL SYSTEM MORPHOGENESIS 41 201 3.782e-08 1.333e-06
133 BEHAVIOR 79 516 3.928e-08 1.374e-06
134 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 54 303 3.96e-08 1.375e-06
135 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 21 67 4.228e-08 1.457e-06
136 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 32 138 5.208e-08 1.782e-06
137 CELL FATE COMMITMENT 44 227 5.914e-08 2.006e-06
138 TUBE MORPHOGENESIS 56 323 5.949e-08 2.006e-06
139 MUSCLE TISSUE DEVELOPMENT 50 275 6.518e-08 2.182e-06
140 POSITIVE REGULATION OF CELL COMMUNICATION 183 1532 6.818e-08 2.266e-06
141 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 25 93 6.956e-08 2.296e-06
142 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 34 154 7.314e-08 2.397e-06
143 RESPONSE TO ORGANIC CYCLIC COMPOUND 121 917 8.142e-08 2.649e-06
144 MUSCLE ORGAN DEVELOPMENT 50 277 8.26e-08 2.656e-06
145 CELLULAR RESPONSE TO HORMONE STIMULUS 82 552 8.335e-08 2.656e-06
146 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 61 368 8.32e-08 2.656e-06
147 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 48 262 9.341e-08 2.957e-06
148 EMBRYONIC ORGAN MORPHOGENESIS 50 279 1.043e-07 3.28e-06
149 RESPONSE TO ALCOHOL 60 362 1.064e-07 3.322e-06
150 EPITHELIAL CELL DEVELOPMENT 38 186 1.128e-07 3.499e-06
151 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 44 232 1.141e-07 3.515e-06
152 VESICLE MEDIATED TRANSPORT 153 1239 1.173e-07 3.59e-06
153 PROTEIN LOCALIZATION 208 1805 1.285e-07 3.909e-06
154 COGNITION 46 251 1.702e-07 5.141e-06
155 GROWTH 65 410 1.734e-07 5.204e-06
156 TELENCEPHALON DEVELOPMENT 43 228 1.864e-07 5.56e-06
157 NEURON PROJECTION DEVELOPMENT 80 545 1.99e-07 5.897e-06
158 MEMBRANE DEPOLARIZATION 19 61 2.068e-07 6.091e-06
159 REGULATION OF AXONOGENESIS 35 168 2.147e-07 6.283e-06
160 NEGATIVE REGULATION OF CELL DEVELOPMENT 52 303 2.438e-07 7.091e-06
161 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 37 184 2.51e-07 7.255e-06
162 RESPONSE TO NITROGEN COMPOUND 113 859 2.597e-07 7.413e-06
163 RESPONSE TO LIPID 116 888 2.588e-07 7.413e-06
164 POSITIVE REGULATION OF CELL DEATH 86 605 2.894e-07 8.211e-06
165 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 79 541 2.944e-07 8.251e-06
166 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 79 541 2.944e-07 8.251e-06
167 ARTERY MORPHOGENESIS 17 51 3.009e-07 8.384e-06
168 REGULATION OF OSSIFICATION 36 178 3.131e-07 8.672e-06
169 CELL CELL SIGNALING 103 767 3.339e-07 9.138e-06
170 CELL PROJECTION ORGANIZATION 117 902 3.32e-07 9.138e-06
171 RHYTHMIC PROCESS 51 298 3.465e-07 9.429e-06
172 CHEMICAL HOMEOSTASIS 114 874 3.556e-07 9.563e-06
173 PATTERN SPECIFICATION PROCESS 65 418 3.544e-07 9.563e-06
174 ACTION POTENTIAL 24 94 3.607e-07 9.644e-06
175 BIOLOGICAL ADHESION 130 1032 3.762e-07 1e-05
176 REGULATION OF ANATOMICAL STRUCTURE SIZE 71 472 3.796e-07 1.003e-05
177 REGULATION OF CELL SIZE 35 172 3.899e-07 1.025e-05
178 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 98 724 4.483e-07 1.172e-05
179 GLAND DEVELOPMENT 62 395 4.731e-07 1.23e-05
180 REGULATION OF PHOSPHOLIPASE ACTIVITY 19 64 4.788e-07 1.231e-05
181 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 20 70 4.79e-07 1.231e-05
182 RESPIRATORY SYSTEM DEVELOPMENT 38 197 5.255e-07 1.343e-05
183 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 17 53 5.622e-07 1.401e-05
184 CELL PART MORPHOGENESIS 88 633 5.593e-07 1.401e-05
185 CORONARY VASCULATURE DEVELOPMENT 14 37 5.691e-07 1.401e-05
186 SECRETION BY CELL 72 486 5.676e-07 1.401e-05
187 RESPONSE TO KETONE 36 182 5.521e-07 1.401e-05
188 MUSCLE CELL DIFFERENTIATION 43 237 5.648e-07 1.401e-05
189 REGIONALIZATION 52 311 5.612e-07 1.401e-05
190 SECRETION 83 588 6.25e-07 1.531e-05
191 POSITIVE REGULATION OF RESPONSE TO STIMULUS 216 1929 6.317e-07 1.539e-05
192 REGULATION OF BODY FLUID LEVELS 74 506 6.573e-07 1.593e-05
193 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 37 191 6.619e-07 1.596e-05
194 POSITIVE REGULATION OF OSSIFICATION 22 84 6.838e-07 1.64e-05
195 REGULATION OF TRANSMEMBRANE TRANSPORT 65 426 7.046e-07 1.681e-05
196 REGULATION OF CELLULAR LOCALIZATION 153 1277 7.468e-07 1.773e-05
197 VENTRICULAR SEPTUM DEVELOPMENT 17 54 7.583e-07 1.791e-05
198 CARDIAC MUSCLE TISSUE DEVELOPMENT 30 140 8.267e-07 1.943e-05
199 NEURON DEVELOPMENT 93 687 8.798e-07 2.057e-05
200 DEVELOPMENTAL GROWTH 54 333 9.201e-07 2.141e-05
201 ION TRANSPORT 151 1262 9.593e-07 2.221e-05
202 REGULATION OF ORGAN GROWTH 20 73 1.002e-06 2.309e-05
203 REGULATION OF ORGAN MORPHOGENESIS 43 242 1.012e-06 2.319e-05
204 EAR DEVELOPMENT 37 195 1.12e-06 2.547e-05
205 MODULATION OF SYNAPTIC TRANSMISSION 50 301 1.122e-06 2.547e-05
206 RESPONSE TO ABIOTIC STIMULUS 127 1024 1.18e-06 2.666e-05
207 REGULATION OF NEURON DEATH 44 252 1.244e-06 2.796e-05
208 HEART MORPHOGENESIS 39 212 1.307e-06 2.923e-05
209 REGULATION OF CELL JUNCTION ASSEMBLY 19 68 1.341e-06 2.985e-05
210 POSITIVE REGULATION OF MAPK CASCADE 69 470 1.356e-06 3.005e-05
211 GLIAL CELL DIFFERENTIATION 29 136 1.393e-06 3.073e-05
212 NEURON PROJECTION GUIDANCE 38 205 1.467e-06 3.22e-05
213 METAL ION TRANSPORT 81 582 1.506e-06 3.29e-05
214 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 30 144 1.544e-06 3.357e-05
215 NEGATIVE REGULATION OF CELL DEATH 111 872 1.674e-06 3.622e-05
216 TAXIS 68 464 1.719e-06 3.704e-05
217 CIRCULATORY SYSTEM PROCESS 57 366 1.748e-06 3.748e-05
218 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 12 30 1.837e-06 3.921e-05
219 PALLIUM DEVELOPMENT 31 153 1.943e-06 4.128e-05
220 REGULATION OF GROWTH 86 633 1.957e-06 4.139e-05
221 POST EMBRYONIC DEVELOPMENT 22 89 1.974e-06 4.157e-05
222 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 41 232 2.065e-06 4.328e-05
223 MUSCLE SYSTEM PROCESS 47 282 2.119e-06 4.422e-05
224 POSITIVE REGULATION OF TRANSPORT 117 936 2.151e-06 4.469e-05
225 MUSCLE ORGAN MORPHOGENESIS 19 70 2.168e-06 4.484e-05
226 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 103 799 2.26e-06 4.654e-05
227 REGULATION OF MEMBRANE POTENTIAL 54 343 2.327e-06 4.749e-05
228 TRANSMEMBRANE TRANSPORT 133 1098 2.327e-06 4.749e-05
229 LUNG ALVEOLUS DEVELOPMENT 14 41 2.404e-06 4.884e-05
230 CARTILAGE DEVELOPMENT 30 147 2.42e-06 4.895e-05
231 CARDIAC CHAMBER MORPHOGENESIS 24 104 2.574e-06 5.185e-05
232 RESPONSE TO STEROID HORMONE 71 497 2.61e-06 5.235e-05
233 EXOCYTOSIS 50 310 2.698e-06 5.387e-05
234 WOUND HEALING 68 470 2.713e-06 5.395e-05
235 DIGESTIVE SYSTEM DEVELOPMENT 30 148 2.801e-06 5.545e-05
236 REGULATION OF ION TRANSPORT 81 592 2.947e-06 5.81e-05
237 REGULATION OF CELLULAR COMPONENT SIZE 53 337 2.969e-06 5.83e-05
238 VASCULOGENESIS 17 59 3.01e-06 5.885e-05
239 REGULATION OF MAPK CASCADE 88 660 3.234e-06 6.297e-05
240 EXTRACELLULAR STRUCTURE ORGANIZATION 49 304 3.447e-06 6.683e-05
241 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 110 876 3.534e-06 6.823e-05
242 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 40 229 3.687e-06 7.09e-05
243 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 8 14 3.762e-06 7.174e-05
244 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 8 14 3.762e-06 7.174e-05
245 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 96 740 3.823e-06 7.261e-05
246 NEGATIVE REGULATION OF LOCOMOTION 44 263 4e-06 7.566e-05
247 CELLULAR RESPONSE TO OXYGEN LEVELS 29 143 4.038e-06 7.607e-05
248 MEMBRANE ORGANIZATION 112 899 4.167e-06 7.817e-05
249 CELLULAR RESPONSE TO KETONE 19 73 4.289e-06 8.014e-05
250 REGULATION OF PROTEIN LOCALIZATION 117 950 4.407e-06 8.202e-05
251 REGULATION OF NEURON APOPTOTIC PROCESS 35 192 5.536e-06 0.0001026
252 REGULATION OF CELLULAR COMPONENT BIOGENESIS 98 767 5.831e-06 0.0001077
253 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 18 68 5.887e-06 0.0001083
254 CELL JUNCTION ORGANIZATION 34 185 6.235e-06 0.0001142
255 CARDIAC VENTRICLE MORPHOGENESIS 17 62 6.338e-06 0.0001156
256 REGULATION OF RECEPTOR ACTIVITY 25 117 6.994e-06 0.0001266
257 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 25 117 6.994e-06 0.0001266
258 CARDIOCYTE DIFFERENTIATION 22 96 7.498e-06 0.0001352
259 REGULATION OF SYNAPTIC PLASTICITY 28 140 7.767e-06 0.0001395
260 SINGLE ORGANISM BEHAVIOR 57 384 7.874e-06 0.0001409
261 ION TRANSMEMBRANE TRANSPORT 103 822 7.937e-06 0.0001415
262 ENDOTHELIAL CELL DEVELOPMENT 14 45 8.337e-06 0.0001481
263 BONE DEVELOPMENT 30 156 8.511e-06 0.0001506
264 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 34 8.555e-06 0.0001508
265 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 10 24 8.743e-06 0.0001535
266 IMMUNE SYSTEM DEVELOPMENT 78 582 9.635e-06 0.0001685
267 CEREBRAL CORTEX DEVELOPMENT 23 105 1.044e-05 0.000182
268 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 22 98 1.067e-05 0.0001852
269 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 31 166 1.128e-05 0.000195
270 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 9 20 1.167e-05 0.0002008
271 CELL PROLIFERATION 87 672 1.173e-05 0.0002008
272 CELLULAR RESPONSE TO PEPTIDE 44 274 1.174e-05 0.0002008
273 CELL DEATH 120 1001 1.199e-05 0.0002044
274 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 12 35 1.205e-05 0.0002047
275 POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 7 12 1.321e-05 0.0002235
276 LUNG CELL DIFFERENTIATION 10 25 1.351e-05 0.0002277
277 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 13 41 1.387e-05 0.0002325
278 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 8 16 1.389e-05 0.0002325
279 DENDRITE DEVELOPMENT 19 79 1.483e-05 0.0002467
280 HINDBRAIN DEVELOPMENT 27 137 1.485e-05 0.0002467
281 MULTICELLULAR ORGANISM METABOLIC PROCESS 21 93 1.528e-05 0.000253
282 POSITIVE REGULATION OF LIPASE ACTIVITY 17 66 1.575e-05 0.0002598
283 REGULATION OF BLOOD CIRCULATION 46 295 1.635e-05 0.0002688
284 ESTABLISHMENT OF PROTEIN LOCALIZATION 160 1423 1.662e-05 0.0002723
285 REGULATION OF EXTENT OF CELL GROWTH 22 101 1.772e-05 0.0002893
286 REGULATION OF HORMONE LEVELS 66 478 1.787e-05 0.0002897
287 ANTERIOR POSTERIOR PATTERN SPECIFICATION 34 194 1.785e-05 0.0002897
288 RESPONSE TO PEPTIDE 58 404 1.815e-05 0.0002933
289 LEARNING 26 131 1.864e-05 0.0002991
290 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 26 131 1.864e-05 0.0002991
291 DIGESTIVE TRACT MORPHOGENESIS 14 48 1.908e-05 0.0003052
292 INOSITOL LIPID MEDIATED SIGNALING 25 124 2.024e-05 0.0003226
293 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 52 352 2.214e-05 0.0003516
294 HOMEOSTATIC PROCESS 151 1337 2.315e-05 0.0003663
295 ORGAN GROWTH 17 68 2.405e-05 0.0003793
296 CARDIAC SEPTUM MORPHOGENESIS 14 49 2.472e-05 0.0003886
297 STRIATED MUSCLE CELL DIFFERENTIATION 31 173 2.634e-05 0.0004127
298 FOREBRAIN CELL MIGRATION 16 62 2.71e-05 0.0004232
299 ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 10 27 2.994e-05 0.0004598
300 EPITHELIAL TO MESENCHYMAL TRANSITION 15 56 2.982e-05 0.0004598
301 MOTOR NEURON AXON GUIDANCE 10 27 2.994e-05 0.0004598
302 REGULATION OF DEPHOSPHORYLATION 29 158 2.988e-05 0.0004598
303 AORTA MORPHOGENESIS 9 22 2.973e-05 0.0004598
304 CELLULAR RESPONSE TO NITROGEN COMPOUND 68 505 3.036e-05 0.0004646
305 MESENCHYME MORPHOGENESIS 12 38 3.105e-05 0.0004721
306 POSITIVE REGULATION OF ORGAN GROWTH 12 38 3.105e-05 0.0004721
307 REGULATION OF LIPASE ACTIVITY 19 83 3.129e-05 0.0004742
308 REGULATION OF ORGANELLE ORGANIZATION 135 1178 3.208e-05 0.0004846
309 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 35 208 3.3e-05 0.000497
310 DIVALENT INORGANIC CATION TRANSPORT 42 268 3.321e-05 0.0004984
311 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 57 404 3.536e-05 0.000529
312 REGULATION OF PHOSPHATASE ACTIVITY 25 128 3.553e-05 0.0005298
313 ENSHEATHMENT OF NEURONS 20 91 3.668e-05 0.0005435
314 AXON ENSHEATHMENT 20 91 3.668e-05 0.0005435
315 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 19 84 3.737e-05 0.0005503
316 TISSUE MIGRATION 19 84 3.737e-05 0.0005503
317 RESPONSE TO EXTERNAL STIMULUS 195 1821 3.877e-05 0.0005691
318 REGULATION OF FAT CELL DIFFERENTIATION 22 106 3.914e-05 0.0005727
319 RESPONSE TO MECHANICAL STIMULUS 35 210 4.051e-05 0.0005909
320 SMOOTH MUSCLE TISSUE DEVELOPMENT 8 18 4.069e-05 0.0005916
321 LIPID PHOSPHORYLATION 21 99 4.146e-05 0.0006001
322 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 12 39 4.153e-05 0.0006001
323 SYNAPSE ORGANIZATION 27 145 4.268e-05 0.0006148
324 CATION TRANSPORT 97 796 4.405e-05 0.0006326
325 EPHRIN RECEPTOR SIGNALING PATHWAY 19 85 4.449e-05 0.0006349
326 HEART PROCESS 19 85 4.449e-05 0.0006349
327 POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 9 23 4.531e-05 0.0006447
328 CELLULAR RESPONSE TO ALCOHOL 23 115 4.881e-05 0.0006924
329 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 166 1517 5.021e-05 0.0007101
330 ACTIN FILAMENT BASED MOVEMENT 20 93 5.099e-05 0.000719
331 LUNG EPITHELIUM DEVELOPMENT 11 34 5.156e-05 0.0007205
332 HEART VALVE DEVELOPMENT 11 34 5.156e-05 0.0007205
333 MULTICELLULAR ORGANISMAL SIGNALING 24 123 5.133e-05 0.0007205
334 REGULATION OF HEART CONTRACTION 36 221 5.201e-05 0.0007246
335 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 18 79 5.356e-05 0.0007439
336 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 12 40 5.494e-05 0.0007585
337 ENDOCRINE PANCREAS DEVELOPMENT 12 40 5.494e-05 0.0007585
338 REGULATION OF CHEMOTAXIS 31 180 5.791e-05 0.0007972
339 CARDIAC MUSCLE CELL CONTRACTION 10 29 6.109e-05 0.0008336
340 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 10 29 6.109e-05 0.0008336
341 REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 10 29 6.109e-05 0.0008336
342 IN UTERO EMBRYONIC DEVELOPMENT 46 311 6.237e-05 0.0008485
343 PANCREAS DEVELOPMENT 17 73 6.391e-05 0.000867
344 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 8 19 6.525e-05 0.0008825
345 NEGATIVE REGULATION OF GENE EXPRESSION 163 1493 6.632e-05 0.0008944
346 KIDNEY EPITHELIUM DEVELOPMENT 24 125 6.72e-05 0.0009017
347 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 9 24 6.725e-05 0.0009017
348 REGULATED EXOCYTOSIS 36 224 6.932e-05 0.0009269
349 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 34 207 7.002e-05 0.0009336
350 MUSCLE CONTRACTION 37 233 7.173e-05 0.0009509
351 REGULATION OF VASCULATURE DEVELOPMENT 37 233 7.173e-05 0.0009509
352 PROSTATE GLAND DEVELOPMENT 12 41 7.193e-05 0.0009509
353 SYNAPTIC SIGNALING 58 424 7.331e-05 0.0009664
354 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 23 118 7.42e-05 0.0009753
355 POSITIVE REGULATION OF NEURON DEATH 16 67 7.541e-05 0.0009865
356 OSSIFICATION 39 251 7.548e-05 0.0009865
357 REGULATION OF MUSCLE TISSUE DEVELOPMENT 21 103 7.64e-05 0.0009958
358 REGULATION OF WOUND HEALING 24 126 7.668e-05 0.0009967
359 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 22 111 8.135e-05 0.001054
360 ESTABLISHMENT OF ENDOTHELIAL BARRIER 10 30 8.496e-05 0.001095
361 PROTEIN AUTOPHOSPHORYLATION 32 192 8.496e-05 0.001095
362 ACTIVATION OF PROTEIN KINASE ACTIVITY 42 279 8.538e-05 0.001097
363 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 7 15 8.613e-05 0.001104
364 POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 13 48 8.843e-05 0.001123
365 REPRODUCTIVE SYSTEM DEVELOPMENT 56 408 8.838e-05 0.001123
366 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 21 104 8.846e-05 0.001123
367 CELL GROWTH 25 135 8.858e-05 0.001123
368 REGULATION OF METAL ION TRANSPORT 47 325 9.12e-05 0.001153
369 REGULATION OF OSTEOBLAST DIFFERENTIATION 22 112 9.354e-05 0.00118
370 GLAND MORPHOGENESIS 20 97 9.525e-05 0.001195
371 REGULATION OF HOMEOSTATIC PROCESS 60 447 9.526e-05 0.001195
372 MEMBRANE ASSEMBLY 9 25 9.748e-05 0.001219
373 CELLULAR RESPONSE TO LIPID 61 457 9.808e-05 0.001224
374 REGULATION OF MUSCLE CELL DIFFERENTIATION 27 152 9.906e-05 0.001232
375 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 14 55 0.0001001 0.001236
376 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 14 55 0.0001001 0.001236
377 SODIUM ION TRANSPORT 26 144 0.0001001 0.001236
378 SYNAPTIC VESICLE CYCLE 19 90 0.0001013 0.001247
379 REGULATION OF STEM CELL DIFFERENTIATION 22 113 0.0001073 0.001318
380 SYNAPSE ASSEMBLY 16 69 0.0001098 0.001345
381 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 13 49 0.0001114 0.001361
382 CELL JUNCTION ASSEMBLY 24 129 0.0001127 0.001373
383 CIRCADIAN RHYTHM 25 137 0.0001133 0.001376
384 RESPONSE TO DRUG 58 431 0.0001153 0.001397
385 NEGATIVE REGULATION OF PHOSPHORYLATION 57 422 0.000119 0.001438
386 CEREBRAL CORTEX CELL MIGRATION 12 43 0.0001198 0.001444
387 GLIAL CELL MIGRATION 11 37 0.0001226 0.00147
388 CARDIAC MUSCLE CELL ACTION POTENTIAL 11 37 0.0001226 0.00147
389 SENSORY ORGAN MORPHOGENESIS 37 239 0.000123 0.001471
390 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 14 56 0.0001235 0.001474
391 AMEBOIDAL TYPE CELL MIGRATION 27 154 0.0001244 0.001477
392 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 123 1087 0.0001245 0.001477
393 RESPONSE TO ESTRADIOL 26 146 0.0001266 0.001499
394 POSITIVE REGULATION OF CELL ADHESION 52 376 0.0001281 0.001513
395 NEUROTRANSMITTER TRANSPORT 27 155 0.0001391 0.001626
396 REGULATION OF ADHERENS JUNCTION ORGANIZATION 13 50 0.0001394 0.001626
397 REGULATION OF SECRETION 85 699 0.0001384 0.001626
398 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 13 50 0.0001394 0.001626
399 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 9 26 0.0001383 0.001626
400 CALCIUM ION TRANSPORT 35 223 0.0001406 0.001632
401 NEGATIVE REGULATION OF CELL ADHESION 35 223 0.0001406 0.001632
402 NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 7 16 0.0001423 0.001647
403 REGULATION OF CYTOSKELETON ORGANIZATION 65 502 0.0001445 0.001668
404 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 18 85 0.0001466 0.001689
405 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 8 21 0.0001514 0.00174
406 REGULATION OF TRANSPORTER ACTIVITY 32 198 0.0001537 0.001761
407 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 27 156 0.0001554 0.001776
408 ENDOCARDIAL CUSHION DEVELOPMENT 10 32 0.0001568 0.00178
409 PROXIMAL DISTAL PATTERN FORMATION 10 32 0.0001568 0.00178
410 BLOOD VESSEL REMODELING 10 32 0.0001568 0.00178
411 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 61 465 0.0001595 0.001806
412 REGULATION OF CELL SUBSTRATE ADHESION 29 173 0.0001611 0.00182
413 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 72 573 0.0001655 0.001865
414 REGULATION OF CELL CELL ADHESION 52 380 0.0001675 0.001882
415 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 13 51 0.0001733 0.001943
416 CLATHRIN COAT ASSEMBLY 6 12 0.0001774 0.001975
417 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 83 684 0.0001771 0.001975
418 NEPHRIC DUCT MORPHOGENESIS 6 12 0.0001774 0.001975
419 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 25 141 0.0001817 0.002017
420 NEGATIVE REGULATION OF AXONOGENESIS 15 65 0.000189 0.002094
421 LUNG MORPHOGENESIS 12 45 0.0001928 0.002115
422 POSITIVE REGULATION OF HEART GROWTH 9 27 0.0001925 0.002115
423 HIPPO SIGNALING 9 27 0.0001925 0.002115
424 REGULATION OF ASTROCYTE DIFFERENTIATION 9 27 0.0001925 0.002115
425 RESPONSE TO ESTROGEN 34 218 0.0001966 0.002152
426 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 29 175 0.0001976 0.002158
427 FORMATION OF PRIMARY GERM LAYER 21 110 0.0002031 0.002213
428 ACTIVATION OF ADENYLATE CYCLASE ACTIVITY 11 39 0.0002064 0.002223
429 REGULATION OF AXON GUIDANCE 11 39 0.0002064 0.002223
430 COCHLEA DEVELOPMENT 11 39 0.0002064 0.002223
431 NEGATIVE CHEMOTAXIS 11 39 0.0002064 0.002223
432 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 11 39 0.0002064 0.002223
433 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 10 33 0.0002086 0.002237
434 EMBRYONIC EYE MORPHOGENESIS 10 33 0.0002086 0.002237
435 CALCIUM ION TRANSMEMBRANE TRANSPORT 27 159 0.0002147 0.002297
436 POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 7 17 0.0002249 0.00239
437 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 7 17 0.0002249 0.00239
438 REGULATION OF MUSCLE ORGAN DEVELOPMENT 20 103 0.000225 0.00239
439 ESTABLISHMENT OF CELL POLARITY 18 88 0.0002324 0.002452
440 REGULATION OF STEM CELL PROLIFERATION 18 88 0.0002324 0.002452
441 REGULATION OF CATION CHANNEL ACTIVITY 18 88 0.0002324 0.002452
442 REGULATION OF ERK1 AND ERK2 CASCADE 36 238 0.0002405 0.002532
443 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 12 46 0.0002416 0.002538
444 CALCIUM ION REGULATED EXOCYTOSIS 17 81 0.0002485 0.002605
445 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 16 74 0.0002616 0.002717
446 CARDIAC MUSCLE CELL DIFFERENTIATION 16 74 0.0002616 0.002717
447 REGULATION OF MUSCLE SYSTEM PROCESS 31 195 0.0002611 0.002717
448 REGULATION OF CELLULAR PROTEIN LOCALIZATION 69 552 0.0002612 0.002717
449 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 13 53 0.0002625 0.00272
450 NEURONAL ACTION POTENTIAL 9 28 0.0002632 0.002722
451 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 11 40 0.0002638 0.002722
452 POSITIVE REGULATION OF CHEMOTAXIS 22 120 0.0002655 0.002733
453 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 33 213 0.0002744 0.002819
454 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 27 162 0.0002934 0.003007
455 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 57 437 0.0002988 0.003055
456 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 12 47 0.0003006 0.003067
457 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 16 75 0.0003077 0.003126
458 SENSORY PERCEPTION OF PAIN 16 75 0.0003077 0.003126
459 SODIUM ION TRANSMEMBRANE TRANSPORT 18 90 0.0003114 0.003157
460 PROSTATE GLAND MORPHOGENESIS 8 23 0.0003147 0.003176
461 NEUROTROPHIN SIGNALING PATHWAY 8 23 0.0003147 0.003176
462 CELLULAR RESPONSE TO INSULIN STIMULUS 25 146 0.0003171 0.003194
463 CARDIAC MUSCLE TISSUE MORPHOGENESIS 13 54 0.0003201 0.003217
464 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 75 616 0.0003227 0.003236
465 EMBRYONIC DIGIT MORPHOGENESIS 14 61 0.0003256 0.003258
466 SPINAL CORD DEVELOPMENT 20 106 0.0003351 0.003346
467 REGULATION OF ERBB SIGNALING PATHWAY 17 83 0.0003373 0.003361
468 GLYCOPROTEIN METABOLIC PROCESS 48 353 0.000339 0.003371
469 OSTEOBLAST DEVELOPMENT 7 18 0.0003421 0.003394
470 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 9 29 0.0003542 0.003499
471 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 9 29 0.0003542 0.003499
472 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 12 48 0.0003713 0.00366
473 RETINA DEVELOPMENT IN CAMERA TYPE EYE 23 131 0.0003741 0.003681
474 SIGNAL RELEASE 28 173 0.0003759 0.00369
475 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 15 69 0.0003789 0.003712
476 REGULATION OF SEQUESTERING OF CALCIUM ION 20 107 0.000381 0.003724
477 NEPHRON DEVELOPMENT 21 115 0.0003831 0.003737
478 REGULATION OF HORMONE SECRETION 38 262 0.0003874 0.003771
479 CRANIAL SKELETAL SYSTEM DEVELOPMENT 13 55 0.0003882 0.003771
480 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 14 62 0.0003893 0.003774
481 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 17 84 0.0003912 0.003784
482 REGULATION OF INTRACELLULAR TRANSPORT 75 621 0.0004104 0.003962
483 REGULATION OF SODIUM ION TRANSPORT 16 77 0.0004211 0.004032
484 ACTOMYOSIN STRUCTURE ORGANIZATION 16 77 0.0004211 0.004032
485 POSITIVE REGULATION OF GLUCOSE TRANSPORT 11 42 0.0004196 0.004032
486 REGULATION OF HEART GROWTH 11 42 0.0004196 0.004032
487 POSITIVE REGULATION OF ION TRANSPORT 35 236 0.0004249 0.004059
488 METENCEPHALON DEVELOPMENT 19 100 0.0004261 0.004063
489 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 73 602 0.0004334 0.004124
490 CYTOSKELETON ORGANIZATION 96 838 0.0004479 0.004247
491 REGULATION OF ION HOMEOSTASIS 31 201 0.0004481 0.004247
492 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 12 49 0.0004555 0.004304
493 INORGANIC ION TRANSMEMBRANE TRANSPORT 71 583 0.000457 0.004304
494 POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 10 36 0.0004569 0.004304
495 REGULATION OF MUSCLE ADAPTATION 14 63 0.0004634 0.004356
496 MEMBRANE BIOGENESIS 9 30 0.0004696 0.004396
497 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 9 30 0.0004696 0.004396
498 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 39 274 0.0004787 0.004473
499 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 30 193 0.0004804 0.00448
500 POSITIVE REGULATION OF GROWTH 35 238 0.000498 0.004635
501 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 6 14 0.0004997 0.004641
502 PLATELET ACTIVATION 24 142 0.0005036 0.004659
503 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 7 19 0.0005036 0.004659
504 REGULATION OF HEART RATE 17 86 0.0005216 0.004808
505 CELL FATE DETERMINATION 11 43 0.0005227 0.004808
506 SEX DIFFERENTIATION 38 266 0.0005229 0.004808
507 PLASMA MEMBRANE ORGANIZATION 31 203 0.0005327 0.004889
508 PROTEIN LOCALIZATION TO CELL PERIPHERY 25 151 0.0005347 0.004898
509 RENAL SYSTEM PROCESS 19 102 0.0005515 0.005041
510 SECOND MESSENGER MEDIATED SIGNALING 26 160 0.0005612 0.005105
511 CIRCADIAN REGULATION OF GENE EXPRESSION 13 57 0.0005618 0.005105
512 ENDOTHELIAL CELL MIGRATION 13 57 0.0005618 0.005105
513 NEGATIVE REGULATION OF TRANSPORT 58 458 0.0005649 0.005124
514 ERBB SIGNALING PATHWAY 16 79 0.0005688 0.005149
515 AXON EXTENSION 10 37 0.0005807 0.005237
516 CAMP MEDIATED SIGNALING 10 37 0.0005807 0.005237
517 SINGLE ORGANISM CELL ADHESION 58 459 0.0005964 0.005368
518 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 17 87 0.0005997 0.005376
519 PEPTIDE CATABOLIC PROCESS 8 25 0.0005988 0.005376
520 CARDIAC ATRIUM DEVELOPMENT 9 31 0.0006141 0.005495
521 RESPONSE TO INSULIN 31 205 0.000631 0.005636
522 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 59 470 0.0006344 0.005655
523 GLUCOSE HOMEOSTASIS 27 170 0.0006404 0.005687
524 CARBOHYDRATE HOMEOSTASIS 27 170 0.0006404 0.005687
525 INSULIN RECEPTOR SIGNALING PATHWAY 16 80 0.000658 0.005831
526 MULTICELLULAR ORGANISMAL WATER HOMEOSTASIS 13 58 0.0006707 0.005933
527 REGULATION OF CYTOPLASMIC TRANSPORT 60 481 0.0006729 0.005941
528 VESICLE LOCALIZATION 33 224 0.0006875 0.006059
529 REGULATION OF RESPONSE TO WOUNDING 53 413 0.0007024 0.006178
530 NEGATIVE REGULATION OF CELL CYCLE 55 433 0.0007201 0.006313
531 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 7 20 0.0007204 0.006313
532 COLLAGEN FIBRIL ORGANIZATION 10 38 0.000731 0.006382
533 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 10 38 0.000731 0.006382
534 REGULATION OF CAMP METABOLIC PROCESS 22 129 0.0007466 0.006506
535 METANEPHROS DEVELOPMENT 16 81 0.0007587 0.006599
536 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 6 15 0.0007754 0.006682
537 NEPHRIC DUCT DEVELOPMENT 6 15 0.0007754 0.006682
538 MORPHOGENESIS OF AN EPITHELIAL FOLD 6 15 0.0007754 0.006682
539 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 27 172 0.0007698 0.006682
540 VENOUS BLOOD VESSEL DEVELOPMENT 6 15 0.0007754 0.006682
541 OVULATION CYCLE 20 113 0.0007887 0.006784
542 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 25 155 0.0007935 0.006787
543 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 11 45 0.0007927 0.006787
544 ADIPOSE TISSUE DEVELOPMENT 9 32 0.000793 0.006787
545 RESPONSE TO ACID CHEMICAL 43 319 0.0008046 0.006832
546 REGULATION OF MAP KINASE ACTIVITY 43 319 0.0008046 0.006832
547 GOLGI VESICLE TRANSPORT 43 319 0.0008046 0.006832
548 TEMPERATURE HOMEOSTASIS 8 26 0.0008035 0.006832
549 ACTIN MEDIATED CELL CONTRACTION 15 74 0.0008282 0.00702
550 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 34 236 0.0008606 0.00728
551 KIDNEY MORPHOGENESIS 16 82 0.0008724 0.007354
552 CARDIAC CONDUCTION 16 82 0.0008724 0.007354
553 REGULATION OF PEPTIDE SECRETION 31 209 0.0008766 0.007376
554 AGING 37 264 0.0008819 0.007407
555 REGULATION OF CELL MATRIX ADHESION 17 90 0.000897 0.007507
556 MESONEPHROS DEVELOPMENT 17 90 0.000897 0.007507
557 MEMORY 18 98 0.0009052 0.007562
558 REGULATION OF RESPONSE TO STRESS 153 1468 0.0009124 0.007595
559 LONG TERM SYNAPTIC POTENTIATION 10 39 0.000912 0.007595
560 REGULATION OF GLUCOSE IMPORT 13 60 0.0009422 0.007815
561 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 13 60 0.0009422 0.007815
562 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 47 360 0.0009503 0.007868
563 NEURAL CREST CELL DIFFERENTIATION 15 75 0.0009584 0.007906
564 MULTI ORGANISM BEHAVIOR 15 75 0.0009584 0.007906
565 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 11 46 0.000966 0.007955
566 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 12 53 0.000971 0.007983
567 STRIATED MUSCLE CONTRACTION 18 99 0.001023 0.008399
568 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 31 211 0.001028 0.008422
569 REGULATION OF CATENIN IMPORT INTO NUCLEUS 8 27 0.001061 0.008659
570 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 8 27 0.001061 0.008659
571 RESPONSE TO CORTICOSTEROID 27 176 0.001098 0.008945
572 POSITIVE REGULATION OF LYASE ACTIVITY 13 61 0.001109 0.008945
573 ENDOCARDIUM DEVELOPMENT 5 11 0.001102 0.008945
574 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 20 116 0.001106 0.008945
575 PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION 20 116 0.001106 0.008945
576 POSITIVE REGULATION OF CYCLASE ACTIVITY 13 61 0.001109 0.008945
577 PROSTATE GLANDULAR ACINUS DEVELOPMENT 5 11 0.001102 0.008945
578 PROTEIN LOCALIZATION TO SYNAPSE 6 16 0.001155 0.009301
579 REGULATION OF VESICLE MEDIATED TRANSPORT 57 462 0.001174 0.009432
580 MULTI MULTICELLULAR ORGANISM PROCESS 31 213 0.001202 0.009643
581 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 40 297 0.00122 0.009771
NumGOOverlapSizeP ValueAdj. P Value
1 PROTEIN KINASE ACTIVITY 115 640 4.223e-16 2.29e-13
2 KINASE ACTIVITY 139 842 4.931e-16 2.29e-13
3 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 108 629 7.98e-14 2.471e-11
4 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 146 992 1.226e-12 2.847e-10
5 PROTEIN SERINE THREONINE KINASE ACTIVITY 81 445 5.394e-12 8.352e-10
6 SEQUENCE SPECIFIC DNA BINDING 149 1037 4.654e-12 8.352e-10
7 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 163 1199 3.871e-11 5.137e-09
8 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 63 328 1.293e-10 1.501e-08
9 REGULATORY REGION NUCLEIC ACID BINDING 119 818 3.497e-10 3.61e-08
10 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 59 315 1.366e-09 1.213e-07
11 RIBONUCLEOTIDE BINDING 223 1860 1.437e-09 1.213e-07
12 ENZYME BINDING 210 1737 2.328e-09 1.802e-07
13 CYTOSKELETAL PROTEIN BINDING 116 819 2.913e-09 2.082e-07
14 DOUBLE STRANDED DNA BINDING 107 764 2.237e-08 1.485e-06
15 PROTEIN DOMAIN SPECIFIC BINDING 91 624 3.935e-08 2.437e-06
16 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 44 226 5.169e-08 3.001e-06
17 ADENYL NUCLEOTIDE BINDING 181 1514 7.648e-08 4.18e-06
18 MOLECULAR FUNCTION REGULATOR 165 1353 8.315e-08 4.292e-06
19 KINASE BINDING 86 606 3.11e-07 1.52e-05
20 CORE PROMOTER PROXIMAL REGION DNA BINDING 59 371 5.718e-07 2.656e-05
21 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 10 20 1.117e-06 4.941e-05
22 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 21 81 1.459e-06 6.162e-05
23 ACTIN BINDING 60 393 1.833e-06 7.094e-05
24 GROWTH FACTOR BINDING 27 123 1.764e-06 7.094e-05
25 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 62 417 3.03e-06 0.0001126
26 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 52 329 3.164e-06 0.000113
27 MACROMOLECULAR COMPLEX BINDING 160 1399 6.479e-06 0.0002229
28 ENZYME ACTIVATOR ACTIVITY 66 471 1.106e-05 0.000367
29 SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 27 136 1.291e-05 0.0004136
30 PROTEIN COMPLEX BINDING 113 935 1.511e-05 0.000468
31 SH3 DOMAIN BINDING 24 116 1.877e-05 0.0005448
32 PROTEIN TYROSINE KINASE BINDING 15 54 1.856e-05 0.0005448
33 METALLOPEPTIDASE ACTIVITY 33 188 2.28e-05 0.0006268
34 SODIUM CHANNEL ACTIVITY 12 37 2.294e-05 0.0006268
35 TRANSMEMBRANE TRANSPORTER ACTIVITY 118 997 2.528e-05 0.0006711
36 BINDING BRIDGING 31 173 2.634e-05 0.0006798
37 ENZYME REGULATOR ACTIVITY 114 959 2.872e-05 0.0007211
38 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 17 70 3.603e-05 0.0008808
39 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 37 228 4.478e-05 0.00102
40 ZINC ION BINDING 132 1155 4.47e-05 0.00102
41 CATION CHANNEL ACTIVITY 45 298 4.5e-05 0.00102
42 CLATHRIN BINDING 16 65 5.083e-05 0.001124
43 RECEPTOR BINDING 162 1476 5.323e-05 0.00115
44 EPHRIN RECEPTOR BINDING 9 24 6.725e-05 0.00142
45 VOLTAGE GATED ION CHANNEL ACTIVITY 32 190 6.917e-05 0.001428
46 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 19 90 0.0001013 0.002046
47 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 43 0.0001198 0.002369
48 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 61 464 0.0001503 0.002909
49 INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 67 527 0.0001966 0.003728
50 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 7 17 0.0002249 0.004178
51 SIGNALING ADAPTOR ACTIVITY 16 74 0.0002616 0.004674
52 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 20 104 0.0002575 0.004674
53 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 43 303 0.0002701 0.004735
54 PHOSPHOLIPID BINDING 49 360 0.0002889 0.004971
55 SYNTAXIN 1 BINDING 7 18 0.0003421 0.005779
56 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 72 588 0.0003571 0.005924
57 SYNTAXIN BINDING 18 93 0.0004734 0.007715
58 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 19 101 0.0004853 0.007773
59 ADRENERGIC RECEPTOR BINDING 7 19 0.0005036 0.00793
60 STEROL BINDING 11 43 0.0005227 0.007961
61 TRANSPORTER ACTIVITY 137 1276 0.0005195 0.007961
62 LIPID BINDING 78 657 0.0005324 0.007978
63 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 14 64 0.0005492 0.008099
64 CORE PROMOTER BINDING 25 152 0.0005913 0.008583
65 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 12 51 0.0006729 0.009617
NumGOOverlapSizeP ValueAdj. P Value
1 CELL JUNCTION 181 1151 2.136e-18 1.248e-15
2 CELL PROJECTION 243 1786 2.292e-16 6.692e-14
3 MEMBRANE REGION 172 1134 5.697e-16 1.109e-13
4 NEURON PART 184 1265 3.231e-15 4.58e-13
5 NEURON PROJECTION 148 942 3.921e-15 4.58e-13
6 SYNAPSE 126 754 4.974e-15 4.841e-13
7 SOMATODENDRITIC COMPARTMENT 108 650 7.095e-13 5.919e-11
8 PLASMA MEMBRANE REGION 131 929 3.501e-10 2.556e-08
9 DENDRITE 76 451 1.013e-09 6.575e-08
10 SYNAPSE PART 94 610 1.419e-09 8.285e-08
11 GOLGI APPARATUS 181 1445 2.438e-09 1.294e-07
12 INTRACELLULAR VESICLE 161 1259 4.842e-09 2.357e-07
13 VOLTAGE GATED SODIUM CHANNEL COMPLEX 10 14 9.574e-09 4.301e-07
14 CELL BODY 78 494 1.235e-08 5.153e-07
15 INTRINSIC COMPONENT OF PLASMA MEMBRANE 197 1649 1.989e-08 7.742e-07
16 POSTSYNAPSE 63 378 4.162e-08 1.519e-06
17 MEMBRANE MICRODOMAIN 52 288 4.533e-08 1.557e-06
18 PLASMA MEMBRANE PROTEIN COMPLEX 78 510 5.009e-08 1.625e-06
19 GOLGI APPARATUS PART 118 893 1.099e-07 3.378e-06
20 SODIUM CHANNEL COMPLEX 10 17 1.478e-07 4.112e-06
21 CELL PROJECTION PART 123 946 1.438e-07 4.112e-06
22 EXCITATORY SYNAPSE 39 197 1.848e-07 4.906e-06
23 VESICLE MEMBRANE 76 512 2.555e-07 6.488e-06
24 CELL LEADING EDGE 57 350 4.004e-07 9.744e-06
25 RECEPTOR COMPLEX 54 327 5.131e-07 1.199e-05
26 CELL SUBSTRATE JUNCTION 62 398 6.173e-07 1.386e-05
27 ANCHORING JUNCTION 72 489 7.182e-07 1.553e-05
28 CELL CELL JUNCTION 60 383 7.705e-07 1.607e-05
29 SARCOLEMMA 27 125 2.452e-06 4.937e-05
30 CYTOPLASMIC VESICLE PART 82 601 2.863e-06 5.573e-05
31 CELL SURFACE 98 757 3.32e-06 6.254e-05
32 NEURON SPINE 26 121 4.142e-06 7.51e-05
33 GOLGI MEMBRANE 92 703 4.244e-06 7.51e-05
34 CATION CHANNEL COMPLEX 32 167 4.68e-06 8.038e-05
35 ENDOSOME 101 793 4.824e-06 8.049e-05
36 ACTIN CYTOSKELETON 64 444 5.983e-06 9.705e-05
37 PERINUCLEAR REGION OF CYTOPLASM 85 642 6.254e-06 9.871e-05
38 AXON 61 418 6.636e-06 0.000102
39 PROTEINACEOUS EXTRACELLULAR MATRIX 54 356 7.171e-06 0.0001074
40 CYTOSKELETON 213 1967 7.86e-06 0.0001148
41 VACUOLE 138 1180 9.517e-06 0.0001356
42 COATED PIT 17 67 1.951e-05 0.0002712
43 APICAL PART OF CELL 53 361 2.207e-05 0.0002997
44 EXTRACELLULAR MATRIX 60 426 2.346e-05 0.0003044
45 LAMELLIPODIUM 31 172 2.343e-05 0.0003044
46 ENDOCYTIC VESICLE 41 256 2.449e-05 0.000311
47 SITE OF POLARIZED GROWTH 28 149 2.611e-05 0.0003244
48 APICAL PLASMA MEMBRANE 45 292 2.71e-05 0.0003297
49 TRANSPORTER COMPLEX 48 321 3.294e-05 0.0003925
50 SYNAPTIC MEMBRANE 41 261 3.876e-05 0.0004527
51 T TUBULE 13 45 4.218e-05 0.000483
52 APICAL JUNCTION COMPLEX 24 128 9.929e-05 0.001115
53 MEMBRANE PROTEIN COMPLEX 117 1020 0.0001044 0.00115
54 ACTIN BASED CELL PROJECTION 30 181 0.0001542 0.001668
55 CLATHRIN COAT OF ENDOCYTIC VESICLE 6 12 0.0001774 0.001884
56 PLASMA MEMBRANE RECEPTOR COMPLEX 29 175 0.0001976 0.002061
57 IONOTROPIC GLUTAMATE RECEPTOR COMPLEX 12 47 0.0003006 0.003079
58 PERINUCLEAR ENDOPLASMIC RETICULUM 6 13 0.0003067 0.003089
59 CLATHRIN VESICLE COAT 8 23 0.0003147 0.003115
60 VACUOLAR MEMBRANE 72 587 0.0003399 0.003308
61 CELL PROJECTION MEMBRANE 42 298 0.0003664 0.003507
62 ACTIN FILAMENT 15 70 0.0004463 0.004204
63 POSTSYNAPTIC MEMBRANE 31 205 0.000631 0.00585
64 CLATHRIN COATED VESICLE MEMBRANE 16 81 0.0007587 0.006924
65 I BAND 21 121 0.0007707 0.006924
66 VESICLE COAT 11 45 0.0007927 0.007015
67 CLATHRIN COATED VESICLE 25 157 0.0009595 0.008364
68 SEMAPHORIN RECEPTOR COMPLEX 5 11 0.001102 0.009467

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Rap1_signaling_pathway_hsa04015 44 206 2.766e-09 1.438e-07
2 MAPK_signaling_pathway_hsa04010 53 295 4.003e-08 7.122e-07
3 Ras_signaling_pathway_hsa04014 45 232 4.109e-08 7.122e-07
4 Hippo_signaling_pathway_hsa04390 34 154 7.314e-08 9.508e-07
5 Focal_adhesion_hsa04510 39 199 2.436e-07 2.533e-06
6 Gap_junction_hsa04540 23 88 3.998e-07 3.465e-06
7 Regulation_of_actin_cytoskeleton_hsa04810 39 208 7.952e-07 5.907e-06
8 FoxO_signaling_pathway_hsa04068 28 132 2.347e-06 1.377e-05
9 PI3K_Akt_signaling_pathway_hsa04151 55 352 2.383e-06 1.377e-05
10 ErbB_signaling_pathway_hsa04012 21 85 3.385e-06 1.76e-05
11 Phospholipase_D_signaling_pathway_hsa04072 29 146 6.202e-06 2.932e-05
12 Sphingolipid_signaling_pathway_hsa04071 25 118 8.194e-06 3.551e-05
13 cAMP_signaling_pathway_hsa04024 34 198 2.768e-05 0.0001081
14 Calcium_signaling_pathway_hsa04020 32 182 2.911e-05 0.0001081
15 Cellular_senescence_hsa04218 28 160 9.724e-05 0.0003371
16 Tight_junction_hsa04530 29 170 0.0001176 0.0003823
17 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 25 139 0.0001439 0.0004401
18 TNF_signaling_pathway_hsa04668 21 108 0.0001553 0.0004488
19 AMPK_signaling_pathway_hsa04152 22 121 0.0002999 0.0008207
20 Hippo_signaling_pathway_multiple_species_hsa04392 9 29 0.0003542 0.0009209
21 Jak_STAT_signaling_pathway_hsa04630 26 162 0.0006804 0.001685
22 mTOR_signaling_pathway_hsa04150 24 151 0.001232 0.002911
23 cGMP_PKG_signaling_pathway_hsa04022 25 163 0.00165 0.003645
24 Apelin_signaling_pathway_hsa04371 22 137 0.001682 0.003645
25 Mitophagy_animal_hsa04137 13 65 0.002044 0.004251
26 Adherens_junction_hsa04520 13 72 0.005181 0.01036
27 Phosphatidylinositol_signaling_system_hsa04070 16 99 0.006367 0.01226
28 VEGF_signaling_pathway_hsa04370 11 59 0.007622 0.01409
29 Wnt_signaling_pathway_hsa04310 21 146 0.007857 0.01409
30 p53_signaling_pathway_hsa04115 12 68 0.008519 0.01442
31 Apoptosis_hsa04210 20 138 0.008597 0.01442
32 HIF_1_signaling_pathway_hsa04066 15 100 0.01569 0.02546
33 Endocytosis_hsa04144 30 244 0.01616 0.02546
34 TGF_beta_signaling_pathway_hsa04350 13 84 0.01848 0.02826
35 Cell_adhesion_molecules_.CAMs._hsa04514 19 145 0.02738 0.04068
36 Autophagy_animal_hsa04140 17 128 0.03171 0.0458
37 Hedgehog_signaling_pathway_hsa04340 8 47 0.03519 0.04945
38 Notch_signaling_pathway_hsa04330 7 48 0.09368 0.1282
39 ECM_receptor_interaction_hsa04512 10 82 0.1311 0.1748
40 Oocyte_meiosis_hsa04114 14 124 0.1357 0.1764
41 Cytokine_cytokine_receptor_interaction_hsa04060 26 270 0.2179 0.2763
42 Neuroactive_ligand_receptor_interaction_hsa04080 26 278 0.2643 0.3273
43 ABC_transporters_hsa02010 5 45 0.3058 0.3698
44 Cell_cycle_hsa04110 12 124 0.3142 0.3713
45 Peroxisome_hsa04146 7 83 0.5232 0.6046
46 Apoptosis_multiple_species_hsa04215 2 33 0.7642 0.8545
47 Necroptosis_hsa04217 11 164 0.794 0.8545
48 NF_kappa_B_signaling_pathway_hsa04064 6 95 0.7987 0.8545
49 Phagosome_hsa04145 10 152 0.8052 0.8545
50 Lysosome_hsa04142 6 123 0.9431 0.9616

Quest ID: 311396551c596d80d3c7b26569a7a7fd